Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1978 Oct;64(2):185–191. doi: 10.1111/j.1476-5381.1978.tb17288.x

E. coli endotoxin shock in the dog; treatment with lidocaine or indomethacin.

J R Fletcher, P W Ramwell
PMCID: PMC1668327  PMID: 361135

Abstract

1 Dogs treated with lidocaine (1 mg kg-1 h-1) or indomethacin (1.5 mg/kg) before and after an LD60 dose (1 mg/kg) of E. coli endotoxin survived for at least 72 h. 2 Although all dogs in both treated groups survived, only those treated with indomethacin were significantly protected against the fall in the arterial blood pressure 1 to 2 min following endotoxin administration. 3 Endotoxin increased the plasma prostaglandin F2alpha (PGF2alpha) concentration in the control and lidocaine-treated groups, however, no increase was observed with indomethacin treatment. 4 Neither lidocaine nor indomethacin alone had any significant effect on the parameters measured in this model. 5 Following the administration of endotoxin, lidocaine-treated animals had significantly decreased plasma fibrinogen concentrations when compared to the other groups. 6 This study suggests that lidocaine, a local anaesthetic and a drug widely used for cardiac arrhythmias, might offer protection in endotoxin shock.

Full text

PDF
189

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altura B. M. Evaluation of neurohumoral substances in local regulation of blood flow. Am J Physiol. 1967 Jun;212(6):1447–1454. doi: 10.1152/ajplegacy.1967.212.6.1447. [DOI] [PubMed] [Google Scholar]
  2. Anderson F. L., Tsagaris T. J., Jubiz W., Kuida H. Prostaglandin F and E levels during endotoxin-induced pulmonary hypertension in calves. Am J Physiol. 1975 May;228(5):1479–1482. doi: 10.1152/ajplegacy.1975.228.5.1479. [DOI] [PubMed] [Google Scholar]
  3. Blaustein M. P., Goldman D. E. Action of anionic and cationic nerve-blocking agents: experiment and interpretation. Science. 1966 Jul 22;153(3734):429–432. doi: 10.1126/science.153.3734.429. [DOI] [PubMed] [Google Scholar]
  4. Culp J. R., Erdös E. G., Hinshaw I. B., Holmes D. D. Effects of anti-inflammatory drugs in shock caused by injection of living E. coli cells. Proc Soc Exp Biol Med. 1971 May;137(1):219–223. doi: 10.3181/00379727-137-35548. [DOI] [PubMed] [Google Scholar]
  5. Diamond G., Forrester J. S. Effect of coronary artery disease and acute myocardial infarction on left ventricular compliance in man. Circulation. 1972 Jan;45(1):11–19. doi: 10.1161/01.cir.45.1.11. [DOI] [PubMed] [Google Scholar]
  6. FEINSTEIN M. B. REACTION OF LOCAL ANESTHETICS WITH PHOSPHOLIPIDS. A POSSIBLE CHEMICAL BASIS FOR ANESTHESIA. J Gen Physiol. 1964 Nov;48:357–374. doi: 10.1085/jgp.48.2.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Fletcher J. R., Herman C. M., Ramwell P. W. Improved survival in endotoxemia with aspirin and indomethacin pretreatment. Surg Forum. 1976;27(62):11–12. [PubMed] [Google Scholar]
  8. Fletcher J. R., Ramwell P. W., Herman C. M. Prostaglandins and the hemodynamic course of endotoxin shock. J Surg Res. 1976 Jun;20(6):589–594. doi: 10.1016/0022-4804(76)90095-0. [DOI] [PubMed] [Google Scholar]
  9. Fletcher J. R., Ramwell P. W. Modification, by aspirin and indomethacin, of the haemodynamic and prostaglandin releasing effects of E. coli endotoxin in the dog. Br J Pharmacol. 1977 Oct;61(2):175–181. doi: 10.1111/j.1476-5381.1977.tb08402.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Flower R. J. Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev. 1974 Mar;26(1):33–67. [PubMed] [Google Scholar]
  11. Greenway C. V., Murthy V. S. Mesenteric vasoconstriction after endotoxin administration in cats pretreated with aspirin. Br J Pharmacol. 1971 Oct;43(2):259–269. [PMC free article] [PubMed] [Google Scholar]
  12. Hall R. C., Hodge R. L. Vasoactive hormones in endotoxin shock: a comparative study in cats and dogs. J Physiol. 1971 Feb;213(1):69–84. doi: 10.1113/jphysiol.1971.sp009368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Harrison D. C., Collinsworth K. A. Antiarrhythmic actions of lidocaine. Annu Rev Med. 1974;25:143–148. doi: 10.1146/annurev.me.25.020174.001043. [DOI] [PubMed] [Google Scholar]
  14. Hauman R. L. Effect of celiac blockade fn intestinal arteriolar resistance and critical closing pressure during endotoxin shock. Surgery. 1968 Oct;64(4):785–790. [PubMed] [Google Scholar]
  15. Hawiger J., Niewiarowski S., Gurewich V., Thomas D. P. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. J Lab Clin Med. 1970 Jan;75(1):93–108. [PubMed] [Google Scholar]
  16. Hinshaw L. B., Solomon L. A., Erdös E. G., Reins D. A., Gunter B. J. Effects of acetylsalicylic acid on the canine response to endotoxin. J Pharmacol Exp Ther. 1967 Sep;157(3):665–671. [PubMed] [Google Scholar]
  17. Kadowitz P. J., Joiner P. D., Hyman A. L. Physiological and pharmacological roles of prostaglandins. Annu Rev Pharmacol. 1975;15:285–306. doi: 10.1146/annurev.pa.15.040175.001441. [DOI] [PubMed] [Google Scholar]
  18. Kocsis J. J., Hernandovich J., Silver M. J., Smith J. B., Ingerman C. Duration of inhibition of platelet prostaglandin formation and aggregation by ingested aspirin or indomethacin. Prostaglandins. 1973 Feb;3(2):141–144. doi: 10.1016/0090-6980(73)90081-6. [DOI] [PubMed] [Google Scholar]
  19. Kwant W. O., Seeman P. The displacement of membrane calcium by a local anesthetic (chlorpromazine). Biochim Biophys Acta. 1969;193(2):338–349. doi: 10.1016/0005-2736(69)90194-1. [DOI] [PubMed] [Google Scholar]
  20. MACLEAN L. D., SPINK W. W., VISSCHER M. B., WEIL M. H. Studies on the circulatory changes in the dog produced by endotoxin from gram-negative microorganisms. J Clin Invest. 1956 Nov;35(11):1191–1198. doi: 10.1172/JCI103373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. NORTHOVER B. J., SUBRAMANIAN G. Analgesic-antipyretic drugs as antagonists of endotoxin shock in dogs. J Pathol Bacteriol. 1962 Apr;83:463–468. [PubMed] [Google Scholar]
  22. NYE S. W., GRAHAM J. B., BRINKHOUS K. M. The partial thromboplastin time as a screening test for the detection of latent bleeders. Am J Med Sci. 1962 Mar;243:279–287. doi: 10.1097/00000441-196203000-00002. [DOI] [PubMed] [Google Scholar]
  23. O'brien J. R. Platelet aggregation: Part I Some effects of the adenosine phosphates, thrombin, and cocaine upon platelet adhesiveness. J Clin Pathol. 1962 Sep;15(5):446–452. doi: 10.1136/jcp.15.5.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. PARFENTJEV I. A., JOHNSON M. L., CLIFFTON E. E. The determination of plasma fibrinogen by turbidity with ammonium sulfate. Arch Biochem Biophys. 1953 Oct;46(2):470–480. doi: 10.1016/0003-9861(53)90218-5. [DOI] [PubMed] [Google Scholar]
  25. Parratt J. R., Sturgess R. M. Evidence that prostaglandin release mediates pulmonary vasoconstriction induced by E. coli endotoxin. J Physiol. 1975 Mar;246(2):79P–80P. [PubMed] [Google Scholar]
  26. Parratt J. R., Sturgess R. M. The effect oa a new anti-inflammatory drug, flurbiprofen, on the respiratory, haemodynamic and metabolic responses to E. coli endotoxin shock in the cat. Br J Pharmacol. 1976 Dec;58(4):547–551. doi: 10.1111/j.1476-5381.1976.tb08622.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Parratt J. R., Sturgess R. M. The effect of indomethacin on the cardiovascular and metabolic responses to E. coli endotoxin in the cat. Br J Pharmacol. 1974 Feb;50(2):177–183. doi: 10.1111/j.1476-5381.1974.tb08559.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Parratt J. R., Sturgess R. M. The possible roles of histamine, 5-hydroxytryptamine and prostaglandin F2alpha as mediators of the acute pulmonary effects of endotoxin. Br J Pharmacol. 1977 Jun;60(2):209–219. doi: 10.1111/j.1476-5381.1977.tb07743.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Parratt J. R., Sturgess R. M. The protective effect of sodium meclofenamate in experimental endotoxin shock. Br J Pharmacol. 1975 Mar;53(3):466P–466P. [PMC free article] [PubMed] [Google Scholar]
  30. Ritchie J. M., Greengard P. On the mode of action of local anesthetics. Annu Rev Pharmacol. 1966;6:405–430. doi: 10.1146/annurev.pa.06.040166.002201. [DOI] [PubMed] [Google Scholar]
  31. Scarpa A., Azzi A. Cation binding to submitochondrial particles. Biochim Biophys Acta. 1968 Apr 29;150(3):473–481. doi: 10.1016/0005-2736(68)90147-8. [DOI] [PubMed] [Google Scholar]
  32. Seeman P. The membrane actions of anesthetics and tranquilizers. Pharmacol Rev. 1972 Dec;24(4):583–655. [PubMed] [Google Scholar]
  33. Somlyo A. P., Somlyo A. V. Vascular smooth muscle. II. Pharmacology of normal and hypotensive vessels. Pharmacol Rev. 1970 Jun;22(2):249–353. [PubMed] [Google Scholar]
  34. Tai H. H., Hollander C. S. Kinetic evidence of a distinct regulatory site on 15-hydroxyprostaglandin dehydrogenase. Adv Prostaglandin Thromboxane Res. 1976;1:171–175. [PubMed] [Google Scholar]
  35. Wangensteen S. L., Geissinger W. T., Lovett W. L., Glenn T. M., Lefer A. M. Relationship between splanchnic blood flow and a myocardial depressant factor in endotoxin shock. Surgery. 1971 Mar;69(3):410–418. [PubMed] [Google Scholar]
  36. Zimmerman B. G., Ryan M. J., Gomer S., Kraft E. Effect of the prostaglandin synthesis inhibitors indomethacin and eicosa-5,8,11,14-tetraynoic acid on adrenergic responses in dog cutaneous vasculature. J Pharmacol Exp Ther. 1973 Nov;187(2):315–323. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES